Haemonetics Corp reports results for the quarter ended in March - Earnings Summary

Haemonetics

11/05/2023 12:46

* Haemonetics Corp  HAE.N  reported quarterly adjusted
earnings of
77 cents​​ per share for the quarter ended in March. The mean
expectation of eight analysts for the quarter was for earnings
of 70 cents per share.
    * Revenue rose 14.9% to $304.42 million from a year ago;
analysts
expected $289.64 million. 
    * Haemonetics Corp's reported EPS for the quarter was 57
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Haemonetics Corp shares had risen by 0.4% this quarter and
gained 5.7% so far this year.
    * The company reported quarterly net income of $29.38
million.
    * Wall Street's median 12-month price target for Haemonetics
Corp
is $100.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 11:45 a.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      0.70           0.77           Beat
 Dec. 31 2022      0.80           0.85           Beat
 Sep. 30 2022      0.67           0.83           Beat
 Jun. 30 2022      0.51           0.58           Beat